COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 525: Articles 5241-5250  | Next

Perceived barriers to cervical cancer screening and motivators for at-home HPV self-sampling during the COVID-19 pandemic: A telephone survey of randomzed controlled trial participants
Parker, S. L., Deshmukh, A. A., Chen, B., Lairson, D. R., Daheri, M., Vernon, S. W., Montealegre, J. R.
10.1101/2022.11.20.22282562 — Posted: 2022-11-22
Reports of deaths are an exaggeration: German (PCR-test-positive) fatality counts during the SARS-CoV-2 era in the context of all-cause mortality
Rockenfeller, R., Günther, M., Mörl, F.
10.1101/2022.11.18.22282534 — Posted: 2022-11-22
Cardiac Arrhythmia after COVID-19 Vaccination versus Non-COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Shi, A., Tang, X., Xia, P., Hao, M., Shu, Y., Nakanishi, H., Smayra, K., Farzad, A., Hu, K., Liu, Q., Pan, S., A. F. Dixon, R., MBBS, Y. W., Cai, P., Yu, P., Li, P.
10.1101/2022.11.21.22282554 — Posted: 2022-11-22
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study
AKAHATA, W., Sekida, T., Nogimori, T., Ode, H., Tamura, T., Kono, K., Kazami, Y., Washizaki, A., Masuta, Y., Suzuki, R., Matsuda, K., Komori, M., Morey, A., Ishimoto, K., Nakata, M., Hasunuma, T., Fukuhara, T., Iwatani, Y., Yamamoto, T., Smith, J. F., Sato, N.
10.1101/2022.11.21.22281000 — Posted: 2022-11-22
Ultrasound treatment inhibits SARS-CoV-2 in vitro infectivity
Veras, F. P., Martins, R., Arruda, E., Cunha, F. Q., Bruno, O. M.
10.1101/2022.11.21.517338 — Posted: 2022-11-21
Differential haplotype expression in class I MHC genes during SARS-CoV-2 infection of human lung cell lines
Francisco Junior, R. d. S., Temerozo, J. R., Ferreira, C. d. S., Martins, Y., Souza, T. M. L., Medina-Acosta, E., de Vasconcelos, A. T. R.
10.1101/2022.11.20.517193 — Posted: 2022-11-21
SARS-CoV-2 exposure in Norwegian rats (Rattus norvegicus) from New York City
Wang, Y., Lenoch, J., Kohler, D., DeLiberto, T., Tang, C., Li, T., Tao, Y., Guan, M., Compton, S., Zeiss, C. J., Hang, J., Wan, X.-F.
10.1101/2022.11.18.517156 — Posted: 2022-11-21
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets
Cox, R., Lieber, C. M., Wolf, J. D., Karimi, A., Lieberman, N. A. P., Sticher, Z. M., Roychoudhury, P., Andrews, M. K., Krueger, R. E., Natchus, M. G., Painter, G. R., Kolykhalov, A., Greninger, A. L., Plemper, R. K.
10.1101/2022.11.20.517271 — Posted: 2022-11-21
Comparative aerosol and surface stability of SARS-CoV-2 Variants of Concern
Bushmaker, T., Yinda, K. C., Morris, D., Holbrook, M., Gamble, A., Adney, D., Bushmaker, C., van Doremalen, N., Fischer, R., Plowright, R., Lloyd-Smith, J. O., Munster, V.
10.1101/2022.11.21.517352 — Posted: 2022-11-21
SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and natural immunity
Beesley, L. J., Moran, K. R., Wagh, K., Castro, L., Theiler, J., Yoon, H., Fischer, W., Hengartner, N. W., Korber, B., Del Valle, S.
10.1101/2022.11.18.517139 — Posted: 2022-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).